These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 28145654)

  • 1. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
    J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of warm ischaemia time on postoperative renal function after partial nephrectomy for clinical T1 renal cell carcinoma: a propensity score-matched study.
    Lee H; Song BD; Byun SS; Lee SE; Hong SK
    BJU Int; 2018 Jan; 121(1):46-52. PubMed ID: 28749082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
    Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
    Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.
    Kopp RP; Liss MA; Mehrazin R; Wang S; Lee HJ; Jabaji R; Mirheydar HS; Gillis K; Patel N; Palazzi KL; Wan JY; Patterson AL; Derweesh IH
    Urology; 2015 Aug; 86(2):312-9. PubMed ID: 26189330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study.
    Takagi T; Kondo T; Iizuka J; Omae K; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    BJU Int; 2016 Jun; 117(6B):E52-9. PubMed ID: 26073989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
    An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
    Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
    Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
    Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
    Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
    Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer.
    Forbes CM; Rendon RA; Finelli A; Kapoor A; Moore RB; Breau RH; Lacombe L; Kawakami J; Drachenberg DE; Pautler SE; Jewett MMA; Saarela O; Liu Z; Tanguay S; Black PC
    Urol Oncol; 2016 Nov; 34(11):486.e17-486.e23. PubMed ID: 27423824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term renal function in patients with renal-cell carcinoma treated surgically: comparison between radical and partial nephrectomy].
    López-Garibay LA; Cendejas-Gómez Jde J; Rodríguez-Covarrubias F; Gómez-Conzatti A; Gabilondo-Navarro F; Sotomayor-de-Zavaleta M
    Rev Invest Clin; 2013; 65(1):7-11. PubMed ID: 23745439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.